Mark J Foley Revance Therapeutics, Inc. (RVNC) insider trading activity

RVNC Quotes by TradingView

Mark J Foley is CEO of Revance Therapeutics, Inc.. Currently has a direct ownership of 995,935 shares of RVNC, which is worth approximately $2.56 Million. The most recent transaction as insider was on Sep 30, 2020, when has been sold 301,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 996K
0% 3M change
8.91% 12M change
Total Value Held $2.56 Million

Mark J Foley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 30 2020
BUY
Grant, award, or other acquisition
-
301,000 Added 29.64%
714,500 Common Stock
Jul 23 2020
BUY
Grant, award, or other acquisition
-
264,439 Added 24.04%
835,670 Common Stock

Also insider at

GKOS
GLAUKOS Corp Healthcare
MJF

Mark J Foley

CEO
Nashville, TN

Track Institutional and Insider Activities on RVNC

Follow Revance Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVNC shares.

Notify only if

Insider Trading

Get notified when an Revance Therapeutics, Inc. insider buys or sells RVNC shares.

Notify only if

News

Receive news related to Revance Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RVNC